Also written as Argireline
Acetyl hexapeptide-8 is a neurotransmitter-inhibiting peptide. It is filed in this library under skin & aging, a navigation topic rather than a statement of where it acts. As a regulatory matter it is used as a cosmetic ingredient, a category that does not require FDA drug approval. It is also written as Argireline.
Regulatory status
Acetyl hexapeptide-8 is used as a cosmetic ingredient.
Cosmetic ingredients are regulated differently from drugs in the United States and do not require FDA approval before sale, which also means they are not reviewed for drug-level effectiveness.
The evidence
11 sources on Acetyl hexapeptide-8 published between 2002 and 2025, each resolved to its journal of record. Titles are listed so you can judge the evidence rather than take a summary on trust.
Nearby
Before any compound, the useful question is what your bloodwork already says. The OPTML Score reads a full panel against optimal ranges.
See the OPTML ScoreEducational reference only. This page explains what has been published about Acetyl hexapeptide-8. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.
Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
All 150 peptides